The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals
India now has 648 medical colleges in 2022 with a whopping 96% increase in the number of Government Medical Colleges (GMC) alone and a 42% increase in the private sector, since 2014
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
Phase-III trials were conducted for safety, and immunogenicity in around 3,100 subjects, in 14 trial sites across India (supported by BIRAC)
It serves to leverage the strengths of various institutions to coordinate AMR surveillance lab networks
The newly built complex of RRIUM, which will be under CCRUM, the apex government organization for research in Unani Medicine
India is home to nearly 80 million diabetics and this number is expected to rise to a staggering 134 million in the next 25 years.
Phase III trial also demonstrated a statistically significant reduction (14%) in hospitalization for any cause, bringing potential relief for patients and reducing burden on healthcare systems
Subscribe To Our Newsletter & Stay Updated
